Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02625961
Brief Title: Study of Pembrolizumab (MK-3475) in Participants With High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057)

First Submitted : December 7, 2015
First Submitted that Met QC Criteria : December 7, 2015
First Posted : December 9, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : February 14, 2020
Last Update Posted : February 18, 2020